Research and Development

Equinome has a dynamic and comprehensive research programme using state-of-the-art genomics technologies to identify and characterise the molecular genetic variants underlying key performance and health traits in the Thoroughbred. Through our associations with elite breeders and trainers, Equinome has access to large numbers of top-class horses at various stages of training and competition that provide subjects for our scientific research programme. Equinome has a well-established and systematic scientific pipeline to commercialise the outputs from the research and development programme, thereby providing customers with the most accurate and informative tests for genetic potential and performance.

Our strong commitment to scientific excellence is reflected in the calibre of scientific papers we have published in peer-reviewed scientific journals such as Animal Genetics, BMC Genomics, Science, Nature Communications, PLoS ONE, Journal of Veterinary Science and Equine Veterinary Journal. Equinome scientists, led by Dr. Emmeline Hill, have been at the forefront of Thoroughbred performance genomics during the last decade and have published widely on gene activity in exercising muscle and the links between genome variation and performance traits in Thoroughbreds. The sophisticated multi-disciplinary approach has been designed to develop a comprehensive understanding of the biology of the exercising horse. We are committed to achieving scientific excellence in all aspects of our research activities, and ensuring the highest levels of scientific integrity within the tests we develop. Any tests that we have commercialised, and all future tests, must adhere to these core values.

Equinome scientists have published more scientific papers on Thoroughbred exercise genomics than any other research group worldwide. Many of these manuscripts are available to view below or may be requested by emailing info@equinome.com.

Click here to view the latest scientific publications by Equinome researchers